Literature DB >> 20471103

Quantifying over-activity in bipolar and schizophrenia patients in a human open field paradigm.

William Perry1, Arpi Minassian, Brook Henry, Meegin Kincaid, Jared W Young, Mark A Geyer.   

Abstract

It has been suggested that a cardinal symptom of mania is over-activity and exaggerated goal-directed behavior. Nevertheless, few attempts have been made to quantify this behavior objectively in a laboratory environment. Having a methodology to assess over-activity reliably might be useful in distinguishing manic bipolar disorder (BD) from schizophrenia (SCZ) during highly activated states. In the current study, quantifiable measures of object interaction were assessed using a multivariate approach. Additionally, symptom correlates of over-activity were assessed. Patients admitted to an acute care psychiatric hospital for either BD with mania or SCZ (paranoid and non-paranoid subtypes) as well as non-patient comparison (NC) participants were assessed in an open field setting referred to as the human Behavioral Pattern Monitor (hBPM). Activity and interactions with novel and engaging objects were recorded for 15min via a concealed video camera and rated for exploratory behavior. Both BD and SCZ patients spent more time near the objects and exhibited more overall walking compared to NC. In contrast, BD patients exhibited greater physical contact with objects (number of object interactions and time spent with objects) relative to SCZ patients or NC participants, as well as more perseverative and socially disinhibited behaviors, indicating a unique pattern of over-activity and goal-directed behavior. Further analyses revealed a distinction between SCZ patients according to their subtype. The current study extends our methodology for quantifying exploration and over-activity in a controlled laboratory setting and aids in assessing the overlap and distinguishing characteristics of BD and SCZ.

Entities:  

Mesh:

Year:  2010        PMID: 20471103      PMCID: PMC2914139          DOI: 10.1016/j.psychres.2010.04.032

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  33 in total

Review 1.  An integrative theory of prefrontal cortex function.

Authors:  E K Miller; J D Cohen
Journal:  Annu Rev Neurosci       Date:  2001       Impact factor: 12.449

2.  Memory-delineated subtypes of schizophrenia: relationship to clinical, neuroanatomical, and neurophysiological measures.

Authors:  Bruce I Turetsky; Paul J Moberg; Lyn Harper Mozley; Stephen T Moelter; Rachel N Agrin; Ruben C Gur; Raquel E Gur
Journal:  Neuropsychology       Date:  2002-10       Impact factor: 3.295

3.  A rating scale for mania: reliability, validity and sensitivity.

Authors:  R C Young; J T Biggs; V E Ziegler; D A Meyer
Journal:  Br J Psychiatry       Date:  1978-11       Impact factor: 9.319

4.  Toward a refined phenomenology of mania: combining clinician-assessment and self-report in the French EPIMAN study.

Authors:  H S Akiskal; E G Hantouche; M L Bourgeois; J M Azorin; D Sechter; J F Allilaire; L Chatenêt-Duchêne; S Lancrenon
Journal:  J Affect Disord       Date:  2001-12       Impact factor: 4.839

5.  Valproate attenuates hyperactive and perseverative behaviors in mutant mice with a dysregulated dopamine system.

Authors:  Rebecca J Ralph-Williams; Martin P Paulus; Xiaoxi Zhuang; Rene Hen; Mark A Geyer
Journal:  Biol Psychiatry       Date:  2003-02-15       Impact factor: 13.382

6.  Reductions in neuronal and glial density characterize the dorsolateral prefrontal cortex in bipolar disorder.

Authors:  G Rajkowska; A Halaris; L D Selemon
Journal:  Biol Psychiatry       Date:  2001-05-01       Impact factor: 13.382

7.  'Utilization behaviour' and its relation to lesions of the frontal lobes.

Authors:  F Lhermitte
Journal:  Brain       Date:  1983-06       Impact factor: 13.501

8.  Heart rate variability in bipolar mania and schizophrenia.

Authors:  Brook L Henry; Arpi Minassian; Martin P Paulus; Mark A Geyer; William Perry
Journal:  J Psychiatr Res       Date:  2009-08-22       Impact factor: 4.791

9.  Cerebral metabolic rates for glucose in mood disorders. Studies with positron emission tomography and fluorodeoxyglucose F 18.

Authors:  L R Baxter; M E Phelps; J C Mazziotta; J M Schwartz; R H Gerner; C E Selin; R M Sumida
Journal:  Arch Gen Psychiatry       Date:  1985-05

10.  Toward a re-definition of subthreshold bipolarity: epidemiology and proposed criteria for bipolar-II, minor bipolar disorders and hypomania.

Authors:  Jules Angst; Alex Gamma; Franco Benazzi; Vladeta Ajdacic; Dominique Eich; Wulf Rössler
Journal:  J Affect Disord       Date:  2003-01       Impact factor: 4.839

View more
  36 in total

Review 1.  Investigating the underlying mechanisms of aberrant behaviors in bipolar disorder from patients to models: Rodent and human studies.

Authors:  Jordy van Enkhuizen; Mark A Geyer; Arpi Minassian; William Perry; Brook L Henry; Jared W Young
Journal:  Neurosci Biobehav Rev       Date:  2015-08-19       Impact factor: 8.989

Review 2.  Animal models of bipolar mania: The past, present and future.

Authors:  R W Logan; C A McClung
Journal:  Neuroscience       Date:  2015-08-24       Impact factor: 3.590

3.  The neuromodulator of exploration: A unifying theory of the role of dopamine in personality.

Authors:  Colin G Deyoung
Journal:  Front Hum Neurosci       Date:  2013-11-14       Impact factor: 3.169

4.  Nitrated meat products are associated with mania in humans and altered behavior and brain gene expression in rats.

Authors:  Seva G Khambadkone; Zachary A Cordner; Faith Dickerson; Emily G Severance; Emese Prandovszky; Mikhail Pletnikov; Jianchun Xiao; Ye Li; Gretha J Boersma; C Conover Talbot; Wayne W Campbell; Christian S Wright; C Evan Siple; Timothy H Moran; Kellie L Tamashiro; Robert H Yolken
Journal:  Mol Psychiatry       Date:  2018-07-18       Impact factor: 15.992

5.  Daily Actigraphy Profiles Distinguish Depressive and Interepisode States in Bipolar Disorder.

Authors:  Anda Gershon; Nilam Ram; Sheri L Johnson; Allison G Harvey; Jamie M Zeitzer
Journal:  Clin Psychol Sci       Date:  2015-11-19

Review 6.  Tamoxifen use for the management of mania: a review of current preclinical evidence.

Authors:  Fernanda Armani; Monica Levy Andersen; José Carlos Fernandes Galduróz
Journal:  Psychopharmacology (Berl)       Date:  2014-01-18       Impact factor: 4.530

7.  Disturbed Prefrontal Cortex Activity in the Absence of Schizophrenia-Like Behavioral Dysfunction in Arc/Arg3.1 Deficient Mice.

Authors:  Xiaoyan Gao; Jasper Grendel; Mary Muhia; Sergio Castro-Gomez; Ute Süsens; Dirk Isbrandt; Matthias Kneussel; Dietmar Kuhl; Ora Ohana
Journal:  J Neurosci       Date:  2019-09-05       Impact factor: 6.167

8.  Dopamine depletion attenuates some behavioral abnormalities in a hyperdopaminergic mouse model of bipolar disorder.

Authors:  Jordy van Enkhuizen; Mark A Geyer; Adam L Halberstadt; Xiaoxi Zhuang; Jared W Young
Journal:  J Affect Disord       Date:  2013-11-16       Impact factor: 4.839

Review 9.  Face and predictive validity of the ClockΔ19 mouse as an animal model for bipolar disorder: a systematic review.

Authors:  M Kristensen; A A Nierenberg; S D Østergaard
Journal:  Mol Psychiatry       Date:  2017-11-07       Impact factor: 15.992

10.  Diagnosis and characterization of mania: Quantifying increased energy and activity in the human behavioral pattern monitor.

Authors:  William Perry; Meghan McIlwain; Karen Kloezeman; Brook L Henry; Arpi Minassian
Journal:  Psychiatry Res       Date:  2016-04-23       Impact factor: 3.222

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.